concept

PROTEIN MISFOLDING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PROTEIN MISFOLDING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

530Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

Summary

PROTEIN MISFOLDING is a concept in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with Aging, Als, Alzheimer. Connected to 224 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	PROTEIN MISFOLDING
Key Genes/Proteins	ALS, NEURODEGENERATIVE DISEASES, MITOCHONDRIAL DYSFUNCTION, OXIDATIVE STRESS, NEURODEGENERATION, TAU
Related Diseases	Als, Neurodegeneration, Ms, Parkinson
Related Pathways	Oxidative Stress

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    PROTEIN_MISFOLDING["PROTEIN MISFOLDING"]
    PROTEIN_MISFOLDING -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    PROTEIN_MISFOLDING -->|"causes"| Parkinson_s_disease["Parkinson's disease"]
    PROTEIN_MISFOLDING -->|"causes"| Huntington_s_disease["Huntington's disease"]
    PROTEIN_MISFOLDING -->|"causes"| cystic_fibrosis["cystic fibrosis"]
    PROTEIN_MISFOLDING -->|"causes"| ALS["ALS"]
    PROTEIN_MISFOLDING -->|"interacts"| Als["Als"]
    PROTEIN_MISFOLDING -->|"regulates"| Ms["Ms"]
    PROTEIN_MISFOLDING -->|"inhibits"| Parkinson["Parkinson"]
    advanced_glycation_end_product["advanced glycation end products"] -->|"activates"| PROTEIN_MISFOLDING
    molecular_chaperones["molecular chaperones"] -.protects against.-> PROTEIN_MISFOLDING
    pharmacological_chaperones["pharmacological chaperones"] -.protects against.-> PROTEIN_MISFOLDING
    TUDCA["TUDCA"] -.protects against.-> PROTEIN_MISFOLDING
    APOPTOSIS["APOPTOSIS"] -->|"causes"| PROTEIN_MISFOLDING
    NEURODEGENERATION["NEURODEGENERATION"] -->|"causes"| PROTEIN_MISFOLDING
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"causes"| PROTEIN_MISFOLDING

Outgoing (303)

Target	Relation	Type	Str
Neurodegenerative Disease	contributes_to	disease	0.95
Neurodegenerative Diseases	contributes_to	disease	0.95
NEURODEGENERATION	contributes_to	process	0.95
Neurodegenerative Diseases	causes	disease	0.95
Alzheimer's Disease	drives	disease	0.95
Alzheimer's Disease	contributes_to	disease	0.91
Therapeutic Targets	involved_in	mechanism	0.90
Parkinson's Disease Neurodegeneration	contributes_to	process	0.90
intercellular transmission	promotes	process	0.90
ALS	associated_with	gene	0.90
Amyotrophic Lateral Sclerosis	contributes_to	disease	0.90
Motor Neuron Degeneration	contributes_to	phenotype	0.85
Parkinson's Disease	contributes_to	disease	0.85
Apoptosis	contributes_to	process	0.80
Protein Aggregation	causes	mechanism	0.80
Als	activates	disease	0.75
Neurodegeneration	activates	disease	0.75
Als	associated_with	disease	0.75
Neurodegeneration	biomarker_for	disease	0.75
cystic fibrosis	causes	disease	0.70
neurodegeneration	promotes	process	0.70
Alzheimer's disease	causes	disease	0.70
Parkinson's disease	causes	disease	0.70
Huntington's disease	causes	disease	0.70
ALS	causes	disease	0.70
NEURODEGENERATIVE DISEASES	interacts_with	gene	0.70
Oxidative Stress	activates	pathway	0.70
Oxidative Stress	associated_with	pathway	0.70
MITOCHONDRIAL DYSFUNCTION	associated_with	gene	0.70
Als	interacts_with	disease	0.65
Ms	regulates	disease	0.65
Parkinson	inhibits	disease	0.65
Als	inhibits	disease	0.65
Ms	inhibits	disease	0.65
Parkinson	expressed_in	disease	0.65
Alzheimer	expressed_in	disease	0.65
Amyotrophic Lateral Sclerosis	expressed_in	disease	0.65
Amyotrophic Lateral Sclerosis	associated_with	disease	0.65
Alzheimer	inhibits	disease	0.65
Ms	activates	disease	0.65
Fibrosis	regulates	disease	0.65
Als	regulates	disease	0.65
Fibrosis	interacts_with	disease	0.65
Neurodegeneration	causes	disease	0.65
Ms	associated_with	disease	0.65
Alzheimer	protects_against	disease	0.65
Neurodegeneration	protects_against	disease	0.65
Dementia	activates	disease	0.65
Parkinson	activates	disease	0.65
Ataxia	activates	disease	0.65

Incoming (227)

Source	Relation	Type	Str
Alzheimer'S	associated_with	disease	0.95
Autophagy	involved_in	pathway	0.95
ALS	associated_with	disease	0.95
L444P variant	causes	biomarker	0.90
Autophagy	inhibits	process	0.90
ALS	causes	disease	0.90
OXIDATIVE STRESS	critical_for	process	0.90
Advanced Glycation End Products	contributes_to	compound	0.85
Ages	promotes	compound	0.85
Pathological Seeds	biomarker_for	biomarker	0.85
Autophagy	regulates	pathway	0.85
SOD1	causes	gene	0.80
ubiquitin-proteasome	mediates	pathway	0.80
autophagy pathway	mediates	pathway	0.80
oxidative stress response	mediates	pathway	0.80
advanced glycation end products	activates	process	0.70
molecular chaperones	protects_against	protein	0.70
pharmacological chaperones	protects_against	drug	0.70
TUDCA	protects_against	drug	0.70
OXIDATIVE STRESS	associated_with	gene	0.70
NEURODEGENERATION	biomarker_for	gene	0.70
apoptosis pathway	mediates	pathway	0.70
TAU	inhibits	protein	0.70
CELL SURVIVAL	protects_against	phenotype	0.65
TDP-43	interacts_with	gene	0.65
TAU	causes	protein	0.65
FUS	regulates	gene	0.65
SETX	inhibits	gene	0.60
SQSTM1	activates	gene	0.60
glutamate signaling	mediates	pathway	0.60
GABARAP	activates	gene	0.60
DNAJB2	inhibits	gene	0.60
DNAJB6	inhibits	gene	0.60
DNAJA1	inhibits	gene	0.60
DNAJB1	inhibits	gene	0.60
DNAJB6	protects_against	gene	0.60
DNAJB6	interacts_with	gene	0.60
PFN1	implicated_in	gene	0.60
HTT	activates	gene	0.60
APOE	interacts_with	gene	0.60
SNCA	associated_with	gene	0.60
SOD1	interacts_with	gene	0.60
SOD1	associated_with	gene	0.60
APOPTOSIS	causes	gene	0.60
NEURODEGENERATION	causes	gene	0.60
NEURODEGENERATIVE DISEASES	causes	gene	0.60
ATG3	associated_with	gene	0.60
NEURODEGENERATIVE DISEASES	associated_with	gene	0.60
SQSTM1	associated_with	gene	0.60
LC3B	associated_with	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

PROTEIN MISFOLDING

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

calcium-dysregulation-comparison

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

nimodipine-als

Neuroresilience Mechanisms and Evidence

Therapeutics

Multiple System Atrophy

CBS/PSP Clinical Trials Guide

Oligodendrocytes

Tau Spreading Mechanism

APOC4 — Apolipoprotein C-IV

ftd-tdp-pathology

Prion vs Tau/Alpha-Synuclein Propagation: Mechanistic Comparison

Huntington's Disease

AI and Machine Learning in Neurodegeneration

Tau Strain Diversity and Conformational Templating in Tauopathies

prion-disease

Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease